The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia
Rivka Yatuv, Micah Robinson, Inbal Dayan-Tarshish, Moshe BaruOmri Laboratories Ltd., Nes Ziona, IsraelAbstract: Hemophilia A is a rare X-linked bleeding disorder caused by lack or dysfunction of coagulation factor VIII (FVIII). Hemophilia A is treated with replacement therapy, but frequent injection...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-08-01
|
| Series: | International Journal of Nanomedicine |
| Online Access: | http://www.dovepress.com/the-use-of-pegylated-liposomes-in-the-development-of-drug-delivery-app-a4992 |